Daniela Sia

Cholangiocarcinoma research, translational science, genomics, preclinical models, precision medicine.

[EASL Education @EASLedu]

🩺 Clinical case preview - tonight’s #EASLMTB!
A 75-year-old male with HCV-related cirrhosis and a new 57 mm sVIII nodule with vascular invasion.

👉 Diagnosis: hepatocellular carcinoma. How will he respond to treatment? What will happen next?

🚨 Register and join the experts' discussion in 30 minutes!
https://t.co/lQtWpGUmpD

@EASLnews @MarcoSanduzzi @VChernyakMD @siadaniela @Vaital73

#EASLMTB #LiverX

[EASL Education @EASLedu]

@MarcoSanduzzi @ma5RN @VChernyakMD 🧬And what about the molecular perspective? How does tumour biology shape treatment decisions?

@siadaniela: 🔬 Biopsy and molecular testing can help target new cells and reverse resistance.

@EASLnews @ma5RN @MarcoSanduzzi @VChernyakMD @Vaital73

#EASLMTB #LiverX

[EASL Education @EASLedu]

Thank you to our amazing panel! 🙏✨
@ma5RN @MarcoSanduzzi @VChernyakMD @siadaniela @Vaital73

Join us next January in Edinburgh for an in-person #EASLMTB episode at the EASL Liver Cancer Summit 2026:

📅 Friday, 23 January 2026 | 10:05 CET
🔗 Event link: https://t.co/d0oibByz3F
👉 EASL LCS 2026 registration link: https://t.co/PeLI1pi3Kv

@EASLnews #LiverX

[Arndt Vogel @ArndtVogel]

Concordance of ctDNA and tissue genomic profiling in biliary tract cancer
@JHepatology
https://t.co/i53bksEIxs
👉concordance in 84.8%,
👉ctDNA revealed 🎯GA in 34.3%
👉high VAF in ctDNA associated w/ poor prognosis
🧐LB valuable option
@myESMO @EASLedu @ILCAnews @curecc #livertwitter

[Jean-Charles Nault @NaultJc]

Our review on "Morphomolecular pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and combined Hepatocellular-Cholangiocarcinoma" was recently released in Am J Pathol @siadaniela
https://t.co/98q8gd4QDD

[Nekisa Zakeri @nekisa_zakeri]

Fantastic roundtable discussions with the experts & Young Investigators! #ILCA2024 @Valeriechew29 @siadaniela @chiarabraconi @graokane @ILCAnews. Look forward to the YI masterclass today on social media & science 🧬👩‍💻@CappuynsSarah @A_DAlessioMD

[Antonio D'Alessio @A_DAlessioMD]

What a start for #ILCA24 ! Enthusiastic participation to the roundtables organised by the Young ILCA committee - so enlightening to hear the career development advice of our stellar speakers! @marinabaretti @graokane @chiarabraconi @Valeriechew29 @ILCAnews

[Grainne O'Kane @graokane]

Why we do what we do @ILCAnews
➡️power of the patient voice from the wonderful @melinda_bachini
💕pay it forward💕
➡️need drug & clinical trial access
➡️PROs in studies
➡️more practical trial design @curecc @UCDCancerTrials @cancertrials_ie #ILCA24

[ILCA @ILCAnews]

Struggling to balance your research with the fast-paced world of social media? You're not alone. Join Sarah Cappuyns at #ILCA24 for our dedicated session to learn the advantages and challenges of using social media in your scientific research.

👀 https://t.co/NMckE9JK8f

[MountSinaiLiver @MountSinaiLiver]

On June 1, 2024, we proudly joined the Liver Life Walk NYC with 34 teams and 294 walkers. Huge thanks to Dr. Douglas Dieterich, this year's Medical Chair. Grateful to everyone who participated and supported us.

#LiverLifeWalk #Gratitude #ALF @DOMSinaiNYC @liverUSA

[Daniela Sia @siadaniela]

Proud of this amazing scientist @emilybramel and thankful to the @curecc for another wonderful annual conference!!

[Sumera Ilyas @SumeraIlyasMD]

Grateful to the scientific community, @staclinds, Juan Valle, and a wonderful co-chair @siadaniela for making the first Basic Science Track at @curecc Annual Conference a huge success. We had remarkable speakers from all over the world in a packed room with robust discussion.

[Sumera Ilyas @SumeraIlyasMD]

The Genetic and Epigenetic Drivers of CCA session at @curecc was a great session with a lively discussion covering:
👉🏼 cancer epigenomics at the single cell level
👉🏼 germine genetics and CCA risk
👉🏼 genetics of CCA subtypes
👉🏼 tumor genotype-immune phenotype relationship

[Daniela Sia @siadaniela]

We are looking for a post-doctoral fellow to join our research group at Mount Sinai in New York City.

Required experience with mice, friendly and teamworker.

To apply:
https://t.co/L77HF2UNwO

[Daniela Sia @siadaniela]

@BravoCorderoLab @ErinBresnahanMD @IcahnMountSinai @zeiss_micro @joseadserias @FdeCastroS @TheMarkFdn @TischCancer @EAriasLab @SesmaLab @ranm_es @de_decarlos @usal Congrats!!!

[MountSinaiLiver @MountSinaiLiver]

Seeking a motivated post-doc to study novel mouse models of cholangiocarcinoma with KRASG12D mutations. Help us explore how KRAS impacts the immune response and therapy outcomes. Apply now: https://t.co/KxEkMHCU1C #CancerResearch #PostDocJobs #NYC #WeFindAWay @DOMSinaiNYC

[Daniela Sia @siadaniela]

We are looking for a post-doctoral fellow to join our research group at Mount Sinai in New York City.

Required experience with mice, friendly and teamworker.

To apply:
https://t.co/L77HF2UNwO

[Stacie Lindsey @staclinds]

Today is World Cholangiocarcinoma Day! #WorldCCADay. Please join us in spreading awareness of CCA and sign the pledge. It's time to #BeClearOnCCA.

[EASL Education @EASLedu]

#EASLStudio:
👉Check regularly the treatment response
👉 Immune check point inhibitors ➡️ have limited effect alone
👉 Do biopsy as much as possible
👉 Molecular profiling (DNA+RNA seq) for fusion & liquid biopsy for mutation identification
🧐 % of 5-yrs survival remains low

[EASL Education @EASLedu]

📢 Don't forget to tune today @ 18:00 CET for the #EASLStudio scheduled in honour of the #WorldCCADay!

📺https://t.co/zfQSizwYfL

🗣️@ThomasBerg24, Katie Kelley, @siadaniela & Juan Valle

#livertwitter @EASLnews